{
    "2019-05-15": [
        [
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)：减持计划期间届满 珠海红杉已累计减持621.55万股",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "珠海红杉",
                        "减持",
                        "621.55万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)：珠海红杉拟减持不超过0.388%的股份",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "珠海红杉",
                        "减持",
                        "0.388%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物：原5%以上股东减持计划已届满 减持股份",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "原股东",
                        "减持",
                        "计划届满"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物：珠海红杉资本股权投资中心拟减持不超过0.388%公司股份 减持股份",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "珠海红杉资本",
                        "减持",
                        "0.388%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}